<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01346033</url>
  </required_header>
  <id_info>
    <org_study_id>VL-2714</org_study_id>
    <nct_id>NCT01346033</nct_id>
  </id_info>
  <brief_title>Evaluation of SCOUT DS in Subjects With Type 2 Diabetes</brief_title>
  <acronym>TCOYD</acronym>
  <official_title>An Evaluation of a Non-invasive Diabetes Screening Device in Subjects With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VeraLight, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VeraLight, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of
      subjects who have been diagnosed with Type 2 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this
      study is to correct an imbalance in the disease prevalence of the data set used to develop
      the SCOUT DS diabetes screening algorithm.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of SCOUT DS algorithm for detecting known type 2 diabetes</measure>
    <time_frame>1 day</time_frame>
    <description>Collect SCOUT DS and Hemoglobin A1c measurements of subjects with Type 2 Diabetes</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">270</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Those with Type 2 diabetes</arm_group_label>
    <description>All subjects have been diagnosed with type 2 diabetes.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Attendees of the Taking Control of Your Diabetes Health Fair, San Diego CA Convention
        Center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age greater than or equal to 18 years

          2. Self-reported diagnosis of type 2 diabetes

        Exclusion Criteria:

          -  Not diagnosed with type 2 diabetes

               -  Diagnosed with type 1 diabetes

               -  Known to be pregnant (Self Reported)

               -  Receiving dialysis or having known renal compromise

               -  Scars, tattoos, rashes or other disruption/discoloration on the left volar
                  forearm.

               -  Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to
                  ultraviolet light, or taking medication known to cause photosensitivity)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin L Kabongo, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Accelovance San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Diego Convention Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2011</study_first_submitted>
  <study_first_submitted_qc>April 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2011</study_first_posted>
  <last_update_submitted>December 3, 2012</last_update_submitted>
  <last_update_submitted_qc>December 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Adults 18 years and older</keyword>
  <keyword>Taking Control of Your Diabetes Health Fair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

